CLINOMICS INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,545 KRW | +1.64% |
|
+6.04% | -39.77% |
| 17/05 | Clinomics Inc. announced that it has received KRW 4 billion in funding | CI |
| 14/05 | Clinomics Inc. announced that it expects to receive KRW 4 billion in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 4.35Cr | - | - | - | - | - | |
| 4.53TCr | - | |||||
| 4.04TCr | ||||||
| 3.79TCr | ||||||
| 3.18TCr | - | |||||
| 2.77TCr |
- Stock Market
- Equities
- A352770 Stock
- Charts Clinomics Inc.
- Sector Chart
